Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19

Affiliations

¹ Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
² Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.
³ Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China Yi2006liu@163.com.

^# Contributed equally.

Comment

Chenyang Lu et al. Ann Rheum Dis. 2020 Jun.

. 2020 Jun;79(6):737-739.

doi: 10.1136/annrheumdis-2020-217460. Epub 2020 Apr 15.

¹ Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
² Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.
³ Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, Sichuan, China Yi2006liu@163.com.

^# Contributed equally.

No abstract available

Keywords: antirheumatic agents; cytokines; inflammation.

Conflict of interest statement

Competing interests: None declared.

Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression.
Zhu L, Xu X, Ma K, Yang J, Guan H, Chen S, Chen Z, Chen G. Zhu L, et al. Am J Transplant. 2020 Jul;20(7):1859-1863. doi: 10.1111/ajt.15869. Epub 2020 Mar 31. Am J Transplant. 2020. PMID: 32181990 Free PMC article.